RecruitingNCT06642831
Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study
Polycystic Ovarian Syndrome (PCOS) in Human Adolescent and Young Adult Females - Biomarker Evaluation Study (PHOEBE)
Sponsor
University Hospital Erlangen
Enrollment
380 participants
Start Date
Jan 31, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.
Eligibility
Sex: FEMALEMin Age: 15 YearsMax Age: 25 Years
Inclusion Criteria2
- Female subjects age 15-25 years
- Signed written informed consent
Exclusion Criteria5
- Less than 1 years from onset of menarche
- Use of hormonal contraceptives
- Documented ongoing pregnancy
- Major ovarian abnormalities, including subject with only one ovary, cysts and solid masses \> 2 cm as detected by transvaginal ultrasound
- Malignancy ( documented malignancy, documentation of current radiation therapy or chemotherapy in medical record)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06642831